Allogeneic Stem Cell Transplantation in Relapsed/Refractory T-, NK/T-cell Lymphomas

Clinical trial NCT02859402 · RECRUITING

Trial details

NCT number: NCT02859402
Sponsor: Keimyung University Dongsan Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

T-cell Non-Hodgkin Lymphoma Lymphoma, Extranodal NK-T-Cell

Start date: 2016-12-01
Primary completion: 2025-12-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.